VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $16,000 | +45.5% | 690 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $11,000 | -21.4% | 690 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $14,000 | +40.0% | 690 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $10,000 | -16.7% | 690 | 0.0% | 0.00% | -42.9% |
| Q2 2017 | $12,000 | +50.0% | 690 | 0.0% | 0.01% | +40.0% |
| Q1 2017 | $8,000 | -20.0% | 690 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $10,000 | -41.2% | 690 | 0.0% | 0.01% | -41.7% |
| Q3 2016 | $17,000 | +21.4% | 690 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $14,000 | -22.2% | 690 | 0.0% | 0.01% | -8.3% |
| Q1 2016 | $18,000 | -99.8% | 690 | -99.1% | 0.01% | -99.8% |
| Q4 2015 | $8,027,000 | +22.1% | 78,971 | +114.3% | 5.36% | +8.0% |
| Q3 2015 | $6,574,000 | -7.4% | 36,856 | +15.4% | 4.96% | -6.5% |
| Q2 2015 | $7,097,000 | -30.2% | 31,945 | -37.6% | 5.30% | -8.6% |
| Q1 2015 | $10,161,000 | -38.5% | 51,157 | -55.7% | 5.80% | +8.4% |
| Q4 2014 | $16,520,000 | +440.2% | 115,439 | +395.3% | 5.35% | +201.8% |
| Q3 2014 | $3,058,000 | +27.0% | 23,306 | +22.1% | 1.77% | +103.1% |
| Q2 2014 | $2,407,000 | +94.7% | 19,086 | +103.6% | 0.87% | +40.4% |
| Q1 2014 | $1,236,000 | – | 9,374 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |